The U.S. Food and Drug Administration (FDA) on Monday classified the recall of Philips' respiratory machines as its most serious type, as their use could cause serious injuries or death.
Aug 14 - The U.S. Food and Drug Administration on Monday classified the recall of Philips'The Dutch medical devices maker started the process on March 29 and has recalled 73,000 devices in the United Sates.
The ventilators being recalled include Trilogy Evo, Evo O2 and EV300, among others. These devices help people with respiratory conditions to keep breathing at a regular rhythm. Philips was recalling the ventilators after detecting contaminants such as dust and dirt from the environment in the air path of some devices.
The company has received 542 reports about this issue, according to the FDA. The health agency said there are currently two reported injuries and one death attributable to the issue.Reporting by Pratik Jain in Bengaluru; Editing by Shounak Dasgupta
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Exor takes 15% stake in Philips for around $2.8 blnHealthcare technology company Philips said on Monday that Dutch investment firm Exor NV has taken a 15% stake in the company in a deal worth around 2.6 billion euros ($2.84 billion).
Read more »
Breakingviews - Exor’s Philips bet looks well-timedExor Chief Executive John Elkann is making a bold but potentially shrewd punt on troubled medical and consumer group Koninklijke Philips . The Agnelli family’s investment company on Monday said it bought a 15% stake in the toothbrushes-to-defibrillators group for 2.6 billion euros ($2.8 billion). The deal, part of a broader push into healthcare, comes as the Dutch group is facing lawsuits and probes by the U.S. Department of Justice relating to faulty breathing devices.
Read more »
Pregnancy, ovulation and urinary tract infection tests are being recalled. Here's what you need to know.The Food and Drug Administration (FDA) is urging consumers to avoid certain consumer testing products. Here's a list.
Read more »
FDA: Avoid using Universal Meditech pregnancy, ovulation testsRECALL ALERT: A variety of products that test for pregnancy, ovulation, urinary tract infections and more, are being recalled. recall
Read more »
Revance's Botox rival gets FDA approval for painful neck muscle conditionThe U.S. health regulator has approved expanding the use of Revance Therapeutics' Daxxify to treat a painful neck muscle condition, intensifying the anti-wrinkle injection's rivalry with AbbVie's Botox.
Read more »
Why the FDA Is Asking Pregnant Women to Avoid KiwifruitZespri organic green kiwifruits shipped to 14 states have been recalled due to potential listeria contamination. Here’s what you need to know to stay safe.
Read more »